Sage Journals: Discover world-class research

Open access

Research article

First published 2023

Pursuit or discontinuation of anti-PD1 after 2 years of treatment in long-term responder patients with non-small cell lung cancer

Camille Ardin, Sarah Humez, Vincent Leroy [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2025

Treatment duration of immune checkpoint inhibitors and overall survival in U.S. veterans with Cancer

Sanya Z Hassan, Marshall J Tague, Mark A Klein [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2024-6

Immune checkpoint inhibitor–related adverse events: Real-world experience from a single veterans’ affairs medical center

Samantha Benz, Katherine A Sherman, Constantin A Dasanu [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2024-4

Clinical outcomes after use of checkpoint inhibitor immunotherapies in people with multiple sclerosis

Alyssa N Nylander, William Rowles, Shane Poole [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2020

Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV

Wolfgang M Brueckl, Martin Reck, Achim Rittmeyer [...]

Clinical Medicine Insights: Oncology

Open access

Research article

First published 2025

Evaluating Patient Adherence and Persistence to Tyrosine-Kinase Inhibitors for Metastatic Renal Cell Carcinoma: A Retrospective Analysis of Real-World Data

Zhaohui Liao Arter, David J Benjamin, Yen Cao [...]

Clinical Medicine Insights: Oncology

Open access

Review article

First published 2024-12

The role of checkpoint inhibitor rechallenge in patients with metastatic renal cell carcinoma: A systematic review

Kanishka Patel, Shuchi Gulati, Nicholas Mitsiades [...]

Kidney Cancer

Open access

Research article

First published 2023

Assessing the Relationship Between Liver Metastases and the Survival of Patients With Non-Small Cell Lung Cancer After Immune Checkpoint Inhibitors Treatment: A Systematic Review and Meta-Analysis

Huilin Xu, Pingpo Ming, Zhenyu Zhao [...]

Integrative Cancer Therapies

Retricted access

Abstract

First published 2020-4

Incidence of Immune Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors,Case Series from Two Tertiary Care Centeers in Dubai,UAE

M Omara, Elamin Abdelgadir, F Khan [...]

Tumori Journal

Open access

Research article

First published 2025

Impact of corticosteroids on the efficacy of first-line pembrolizumab plus chemotherapy in patients with advanced non-small-cell lung cancer

Amytis Roboubi, Eric Wasielewski, Soraya Bordier [...]

Therapeutic Advances in Medical Oncology

Search results